ATAI ATAI Life Sciences NV
Price (delayed)
$1.39
Market cap
$233.25M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.8
Enterprise value
$227.09M
Highlights
ATAI's EPS has dropped by 122% since the previous quarter and by 86% year-on-year
The net income has plunged by 121% from the previous quarter and by 92% YoY
Key stats
What are the main financial stats of ATAI
Market
Valuations
Earnings
Shares outstanding
167.8M
Market cap
$233.25M
Enterprise value
$227.09M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.6
Price to sales (P/S)
674.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
686.07
Revenue
$331,000
Gross profit
$331,000
Operating income
-$105.98M
Net income
-$128.6M
EBIT
-$125.48M
EBITDA
-$124.54M
Free cash flow
-$80.13M
Per share
Balance sheet
Liquidity
EPS
-$0.8
EPS diluted
-$0.8
Free cash flow per share
-$0.5
Book value per share
$0.87
Revenue per share
$0
TBVPS
$1.23
Total assets
$197.52M
Total liabilities
$51.2M
Debt
$23.81M
Equity
$145.72M
Working capital
$94.43M
Debt to equity
0.16
Current ratio
5.81
Quick ratio
5.43
Net debt/EBITDA
0.05
Margins
Efficiency
Dividend
EBITDA margin
-37,625.7%
Gross margin
100%
Net margin
-38,852.9%
Operating margin
-32,017.2%
Return on assets
-52.7%
Return on equity
-66%
Return on invested capital
-57.4%
Return on capital employed
-70.5%
Return on sales
-37,907.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATAI stock price
How has the ATAI Life Sciences stock price performed over time
Intraday
-4.14%
1 week
-11.46%
1 month
-38.77%
1 year
-24.46%
YTD
4.51%
QTD
4.51%
Financial performance
How have ATAI Life Sciences's revenue and profit performed over time
Revenue
$331,000
Gross profit
$331,000
Operating income
-$105.98M
Net income
-$128.6M
Gross margin
100%
Net margin
-38,852.9%
The net margin has dropped by 153% since the previous quarter and by 94% year-on-year
The net income has plunged by 121% from the previous quarter and by 92% YoY
ATAI Life Sciences's operating income has increased by 18% YoY and by 3.8% from the previous quarter
ATAI Life Sciences's operating margin has increased by 17% YoY but it has decreased by 10% from the previous quarter
Growth
What is ATAI Life Sciences's growth rate over time
Valuation
What is ATAI Life Sciences stock price valuation
P/E
N/A
P/B
1.6
P/S
674.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
686.07
ATAI's EPS has dropped by 122% since the previous quarter and by 86% year-on-year
The equity has declined by 45% year-on-year and by 13% since the previous quarter
The P/B is 28% more than the last 4 quarters average of 1.3
ATAI Life Sciences's revenue has decreased by 12% QoQ
ATAI's P/S is 5% below its last 4 quarters average of 742.6
Efficiency
How efficient is ATAI Life Sciences business performance
ATAI's ROS has dropped by 162% since the previous quarter and by 120% year-on-year
The company's return on equity has shrunk by 156% QoQ and by 141% YoY
ATAI's ROA has dropped by 146% since the previous quarter and by 126% year-on-year
The company's return on invested capital has shrunk by 144% QoQ and by 35% YoY
Dividends
What is ATAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATAI.
Financial health
How did ATAI Life Sciences financials performed over time
ATAI's quick ratio is down by 49% year-on-year and by 15% since the previous quarter
The current ratio has contracted by 47% YoY and by 13% from the previous quarter
The debt is 84% smaller than the equity
The company's debt to equity has surged by 167% YoY and by 33% QoQ
The equity has declined by 45% year-on-year and by 13% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.